Opaleye Management Inc. Theravance Biopharma, Inc. Transaction History

Opaleye Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$10.16 - $11.92 $28,488 - $33,423	-2,804 Reduced 0.51%	543,500 $5.63 Million
Q1 2023 May 12, 2023	BUY	$9.87 - $11.44 $4.53 Million - $5.25 Million	458,704 Added 523.63%	546,304 $5.93 Million
Q4 2022 Feb 10, 2023	BUY	$9.65 - $11.34 $845,340 - $993,384	87,600 New	87,600 $982,000
Q4 2017 Feb 09, 2018	SELL	$25.82 - $35.66 $4.65 Million - $6.42 Million	-180,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$23.88 - $34.96 $4.3 Million - $6.29 Million	180,000	180,000 $6.16 Million

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.